GLOBAL HEALTH INSIGHTS

Home › Vaccines › Bringing rotavirus vaccines to Bangladesh

Bringing rotavirus vaccines to Bangladesh

Zain Ali May 2, 2016     No Comment    

Diseases like cholera and smallpox have become widely known cultural symbols for human suffering and medical progress. The same can hardly be said for rotavirus – outside of doctors and diarrhoeal disease specialists, the word ‘rotavirus’ has failed to find a foothold in everyday speech. Despite this, rotavirus is currently the most common cause of childhood diarrhoea in the world. It is so ubiquitous that nearly every human child in the world will be infected once by the age of five.

Unlike cholera, improved sanitation and living standards have not eliminated rotavirus from advanced economies. Improved access to care for children in industrialized nations has meant that rotavirus deaths are rare in those settings. In spite of this progress, the global burden of rotavirus mortality is staggering – in 2013 it caused over 200,000 preventable child deaths, almost exclusively in resource-poor settings.

It is only recently that we have come to appreciate the scale of death caused by rotavirus. Without the knowledge gained from demographic surveillance in poor countries it is entirely plausible that rotavirus infections would have remained an obscure and minor problem in paediatric care.

Diagnosing the problem: rotavirus surveillance in the global South

icddr,b—an international health research institute based in Bangladesh—is a centre for public health and biomedical research. icddr,b strives to bring the insights of modern science to the health concerns of resource-poor communities in the global South.

icddr,b has been carrying out detailed medical and demographic surveillance of extremely poor communities in Bangladesh since the 1960s. Dr K. Zaman, a senior scientist and epidemiologist at icddr,b, has conducted research to determine the prevalence of rotavirus as a cause of childhood diarrhoea in Bangladesh.

Dr Zaman’s team, in collaboration with Dr David Sack from the Johns Hopkins Bloomberg School of Public Health, studied all children under five who were admitted for care in two icddr,b surveillance clinics, from 2000 to 2006. They tested for the presence of rotavirus in children presenting with severe diarrhoea and found that 33% of these children tested positive for rotavirus – conclusively demonstrating that it should a serious target for policy in Bangladesh.

These findings – combined with the results of rotavirus surveillance in poor communities across the globe – have contributed to an evolving picture of rotavirus as a primary target for global public health and humanitarian aid.

Delivering the cure: rotavirus vaccine trials in Bangladesh

Oral rotavirus vaccines were first introduced into industrialized nations in 2006. Hospitalizations for severe rotavirus infections were rapidly reduced in these countries, falling by as much as 80% in the United States. The WHO now lists rotavirus vaccines on its List of Essential Medicines. Gavi, the Vaccine Alliance supports the introduction of rotavirus vaccines to the global South as one of its cornerstone objectives.

Successful introduction of new vaccinations necessitates conducting region-specific safety and efficacy trials. This is of particular concern for oral vaccines – for reasons still poorly understood, some oral vaccines shown to be effective in industrialized settings show reduced efficacy when introduced to resource-poor communities.

Dr Zaman’s team – with funding from Gavi and Merck – has recently conducted a clinical trial to determine the safety and efficacy of oral rotavirus vaccination in Bangladesh. The vaccines were shown to be both safe and effective in this context – but the measured efficacy was substantially lower than that previously seen in more industrialized nations. Whereas rotavirus vaccines have an efficacy of over 80% in advanced economies, this drops to less than 50% in resource-poor communities in Bangladesh and Vietnam.

The implications of these findings are twofold:

  • The vaccines are currently effective enough to justify WHO proposals for expanded rotavirus immunization
  • There is a loss of efficacy in resource-poor settings and further work must be done to maximize the returns from immunization programmes

The work done by icddr,b and other research institutes in the global South has pushed rotavirus out of obscurity and into the forefront of the global development agenda. Hopefully, these efforts will one day elevate this modest virus to the ranks of polio and cholera – a potent symbol of humankind’s capacity to overcome suffering.

Zain Ali (a freelance science writer based in Bangladesh)

Vaccines

 Previous Post

Breastfeeding: The benefits behind the biology

― September 14, 2015

Next Post 

Closing the gap on vaccine efficacy in the ‘global south’

― May 5, 2016

Author: Zain Ali

Related Articles

icddr,b communications ― August 21, 2022 | No Comment

A letter from a dreamer

‘When you want something, all the universe conspires in helping you to achieve it’- a popular quote by Paulo Coelho,

icddr,b communications ― May 28, 2022 | No Comment

When there is a will, there is a way

Farasha Bashir ― July 4, 2021 | No Comment

Better Health District Model: stakeholder engagement for strengthening the 24/7 EmONC services

Farasha Bashir ― June 3, 2021 | No Comment

Distribution of Labour Room Management Protocol in Healthcare Facilities

Farasha Bashir ― December 5, 2020 | No Comment

Capacity Development Workshop of Health Professional on Data Analysis and Thesis Writing

Farasha Bashir ― October 5, 2020 | No Comment

Logistics distribution at OGSB Maternity Hospital for strengthening Infection Prevention and Control measures

Farasha Bashir ― September 23, 2020 | No Comment

Online workshop with newborn experts for Newborn Signal Functions

Farasha Bashir ― August 29, 2020 | No Comment

Global Fund Grant application on HIV

Leave a Reply Cancel reply

You must be logged in to post a comment.

About Global Health Insights

Global Health Insights is an icddr,b produced and curated blog that brings to light the motivation behind the science. All opinions expressed in these articles belong to the authors and are not endorsed by icddr,b.

About icddr,b

icddr,b is a Bangladesh-based international health research institute that strives to solve key public health problems through high quality scientific research and innovation. Policy makers and practitioners utilise our evidence and expertise to improve health outcomes and prevent premature death and disability worldwide. Established more than 50 years ago, we continue to provide life-saving services to the people of Bangladesh, and to nurture the next generation of global health leaders.

Recent Posts

  • A letter from a dreamer
  • When there is a will, there is a way
  • Better Health District Model: stakeholder engagement for strengthening the 24/7 EmONC services
  • Distribution of Labour Room Management Protocol in Healthcare Facilities
  • Capacity Development Workshop of Health Professional on Data Analysis and Thesis Writing

Subscribe

Author List

  • admin (2)
  • Aminul Islam (1)
  • Dr. K. Zaman (1)
  • Farasha Bashir (25)
  • icddr,b communications (20)
  • Liza Talukder (1)
  • M Nazim Uddin (1)
  • Monjur Ahmed (5)
  • Muhammad Asaduzzaman (2)
  • Shafiul Khan (5)
  • Sharful Islam Khan (1)
  • Tahmeed Ahmed (1)
  • Zain Ali (11)
Copyright © 2023 icddr,b. All Rights Reserved.